|
| Exchange Received Time 06/08/2018 17:03:52 Exchange Disseminated Time 06/08/2018 17:03:58 Time Taken 00:00:06 | FREDUN PHARMACEUTICALS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve 1. The Unaudited Financial Results of the Company for the Quarter ended June 30, 2018;
2. Discuss raising of funds by way of Issuance of Securities including but not limited to Equity Shares and / or Convertible Debentures / Bonds / Cumulative Redeemable Preference Shares or any other Securities convertible into Equity / Preferential Issue / Rights Issue / Warrants or through any other permissible mode or combination thereof, as may be most beneficial to the Company; as may be permitted under the applicable rules & regulations of the Companies Act, 2013 and / or SEBI; subject to the approval of the members of the Company, if required and other appropriate approvals. |
|
|